Table 1.

Baseline participant characteristics

Characteristic	Participants (N = 32)
	n	%
Female	16	50.0
Ethnicity
Caucasian	29	90.62
Asian	1	3.13
Latino	2	6.25
Single	25	78.1
Married	7	21.9
Employment
Full time	15	46.9
Part time	7	21.9
Student	5	15.6
Unemployed	5	15.6
	Mean	SD
Age	31.41	8.89
Number of Past SRI Trials	2.63	1.38

Note: Six participants received medication changes during the study as follows: 1) Added bupropion at week 16; 2) SRI plus clonazepam was changed to venlafaxine, clonazepam, and bupropion at week 16; 3) Added clonazepam at week 12; 4) Added clonazepam at week 8; 5) SRI changed to fluoxetine at week 24; 6) Added propranolol and buspirone at week 6, then taken off all medications including SRI at week 12.